Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities
Guardado en:
Autores principales: | Ricardo Gómez-Nieto, Dolores E. López, Norberto Garcia-Cairasco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b67a4d53cb8f487096d882c4b764e047 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Temporal Lobe Epilepsy and Psychiatric Comorbidity
por: Valerio Vinti, et al.
Publicado: (2021) -
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
por: Leontina Elena Filipiuc, et al.
Publicado: (2021) -
Separating the true from the false: A rapid HPTLC-ESI-MS method for the determination of cannabinoids in different oils
por: Theresa Schmidt, et al.
Publicado: (2021) -
Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
por: Wakshlag JJ, et al.
Publicado: (2020) -
Managing reproductive problems in women with epilepsy of childbearing age
por: Wanlin Lai, et al.
Publicado: (2021)